Andrea Charles | 08/08/2011
Kimberly Myers, Office of Biorepositories and Biospecimen Research, National Cancer Institute, NIH, DHHS, joins Andrea Charles from Pharma IQ, for an update on the progess of the NCI's Centre for Biospecimen Science and Standards, and how it fits into the greater structure and goals of the NCI and the OBBR. Myers also shares her thoughts on standardisation, global harmonisation and collaboration and advice for setting up and managing a biobank.
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
SmartLab Exchange USA
April 20-21, 2026
The Logan, Philadelphia, USA
Register Now |
View Agenda |
Learn More